Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ICUI Relative to the S&P 500

ICUI Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the ICU Medical, Inc. (NASD:ICUI) seasonal charts above shows that a Buy Date of February 3 and a Sell Date of June 29 has resulted in a geometric average return of 7.06% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 2.17% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding either the largest or second largest market share position in all its reporting segments: Infusion consumables (#1 market share, 40% of companywide revenue), IV solutions (#2 market share behind Baxter, 24% of companywide revenue), Infusion systems (#2 market share behind Becton Dickson, 32% of companywide revenue), and Critical care (4% of companywide revenue). The combined entity remains primarily U.S. focused, generating roughly 75% of its sales domestically.

To download ICUI seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ICUI